tradingkey.logo

Autonomix Medical Inc

AMIX

1.060USD

+0.010+0.95%
Cierre 09/19, 16:00ETCotizaciones retrasadas 15 min
4.26MCap. mercado
PérdidaP/E TTM

Autonomix Medical Inc

1.060

+0.010+0.95%
Más Datos de Autonomix Medical Inc Compañía
Autonomix Medical, Inc. is a medical device company, which is focused on advancing technologies to treat diseases involving the peripheral nervous system. Its technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate peripheral neural signals with up to 1,000 times sensitivity. It is developing a two-fold technology that can both detect malfunctioning neural signals and ablate nerves in one simple procedure for pain management. It is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform with the potential to address dozens of indications, including in cardiology, renal denervation, and chronic pain management across a disease spectrum. Its Autonomix catheter is equipped with a microchip that converts analog signals from the body to a digital signal that can be sent directly to a computer screen.
Información de la empresa
Símbolo de cotizaciónAMIX
Nombre de la empresaAutonomix Medical Inc
Fecha de salida a bolsaJan 29, 2024
Director ejecutivoMr. Bradley (Brad) Hauser
Número de empleados8
Tipo de seguridadOrdinary Share
Fin del año fiscalJan 29
Dirección21 Waterway Ave, Suite 300
CiudadTHE WOODLANDS
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal77380
Teléfono18322777816
Sitio Webhttps://autonomix.com/
Símbolo de cotizaciónAMIX
Fecha de salida a bolsaJan 29, 2024
Director ejecutivoMr. Bradley (Brad) Hauser
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Landy Toth
Mr. Landy Toth
Chief Technology Officer
Chief Technology Officer
101.31K
-2.12%
Mr. Robert Schwartz
Mr. Robert Schwartz
Chief Medical Officer
Chief Medical Officer
35.77K
-8.42%
Mr. Bradley (Brad) Hauser
Mr. Bradley (Brad) Hauser
President, Chief Executive Officer
President, Chief Executive Officer
11.25K
--
Mr. Trent N. Smith
Mr. Trent N. Smith
Chief Financial Officer
Chief Financial Officer
3.75K
-68.52%
Dr. Christopher Capelli, M.D.
Dr. Christopher Capelli, M.D.
Independent Director
Independent Director
3.75K
--
Mr. Walter V. Klemp
Mr. Walter V. Klemp
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Ms. Lori H. Bisson
Ms. Lori H. Bisson
Executive Vice Chairman of the Board
Executive Vice Chairman of the Board
--
--
Mr. Jonathan P. Foster
Mr. Jonathan P. Foster
Independent Director
Independent Director
--
--
Mr. David Andrew Robins
Mr. David Andrew Robins
Independent Director
Independent Director
--
-100.00%
Ms. Jenene Thomas
Ms. Jenene Thomas
Investor Relations
Investor Relations
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Landy Toth
Mr. Landy Toth
Chief Technology Officer
Chief Technology Officer
101.31K
-2.12%
Mr. Robert Schwartz
Mr. Robert Schwartz
Chief Medical Officer
Chief Medical Officer
35.77K
-8.42%
Mr. Bradley (Brad) Hauser
Mr. Bradley (Brad) Hauser
President, Chief Executive Officer
President, Chief Executive Officer
11.25K
--
Mr. Trent N. Smith
Mr. Trent N. Smith
Chief Financial Officer
Chief Financial Officer
3.75K
-68.52%
Dr. Christopher Capelli, M.D.
Dr. Christopher Capelli, M.D.
Independent Director
Independent Director
3.75K
--
Mr. Walter V. Klemp
Mr. Walter V. Klemp
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Desglose de ingresos
Sin datos
Sin datos
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: dom., 14 de sep
Actualizado: dom., 14 de sep
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Klemp (Walter V.)
2.54%
BioStar Ventures III, L.P.
2.03%
Heights Capital Management, Inc.
1.95%
Toth (Landy)
1.71%
Mariner Wealth Advisors
1.69%
Otro
90.08%
Accionistas
Accionistas
Proporción
Klemp (Walter V.)
2.54%
BioStar Ventures III, L.P.
2.03%
Heights Capital Management, Inc.
1.95%
Toth (Landy)
1.71%
Mariner Wealth Advisors
1.69%
Otro
90.08%
Tipos de accionistas
Accionistas
Proporción
Individual Investor
5.84%
Investment Advisor
4.12%
Corporation
2.03%
Hedge Fund
0.38%
Research Firm
0.29%
Investment Advisor/Hedge Fund
0.17%
Otro
87.17%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
39
859.06K
17.01%
+144.42K
2025Q1
38
911.14K
32.77%
+69.62K
2024Q4
37
970.61K
39.41%
+334.04K
2024Q3
33
498.18K
43.25%
+16.51K
2024Q2
26
438.67K
42.98%
+436.93K
2024Q1
16
314.97K
29.85%
+314.97K
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Klemp (Walter V.)
150.75K
5.42%
--
--
Oct 25, 2024
BioStar Ventures III, L.P.
120.82K
4.35%
+1.00
+0.00%
Oct 25, 2024
Heights Capital Management, Inc.
116.09K
4.18%
-18.91K
-14.01%
Dec 31, 2024
Toth (Landy)
101.31K
3.64%
--
--
Oct 25, 2024
Mariner Wealth Advisors
100.64K
3.62%
+25.00
+0.02%
Mar 31, 2025
Foster (Jonathan P.)
36.56K
1.31%
--
--
Oct 25, 2024
Schwartz (Robert)
35.76K
1.29%
+1.00
+0.00%
Oct 25, 2024
Ikarian Capital LLC
20.00K
0.72%
--
--
Mar 31, 2025
Ver más
ETFs relacionados
Nombre
Proporción
Sin datos
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
Fecha
Tipo
Relación
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
KeyAI